LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+694.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+694.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
500.9x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$9.52M+7.6%
2024$8.84M+287.5%
2023$2.28M+11910.5%
2022$19000.00+100.2%
2021$-10.32M+81.2%
2020$-54.87M-68491.3%
2019$-80000.00-